The Clinical Biomanufacturing Facility (CBF) has over 16 years experience producing biological Investigational Medicinal Products (IMPs) according to GMP for early phase clinical trials.
The first patient to receive gene therapy for an incurable type of blindness was treated at the John Radcliffe Hospital as part of a trial led by Oxford University.